Ryu, Jayoung
Barkal, Sam
Yu, Tian
Jankowiak, Martin
Zhou, Yunzhuo http://orcid.org/0000-0003-3827-8916
Francoeur, Matthew
Phan, Quang Vinh
Li, Zhijian
Tognon, Manuel http://orcid.org/0000-0002-6707-2071
Brown, Lara
Love, Michael I.
Bhat, Vineel http://orcid.org/0000-0002-6583-8176
Lettre, Guillaume http://orcid.org/0000-0002-7740-3399
Ascher, David B. http://orcid.org/0000-0003-2948-2413
Cassa, Christopher A. http://orcid.org/0000-0002-5771-9177
Sherwood, Richard I. http://orcid.org/0000-0001-7427-7713
Pinello, Luca http://orcid.org/0000-0003-1109-3823
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (UM1HG012010, 1R01HL164409, 1R35HG010717-01, R01HG010372, 1R01HL164409, R01HG010372, UM1HG012010, 1R01HL164409, 1R01GM143249)
Department of Health | National Health and Medical Research Council (GNT1174405, GNT1174405)
Victorian Government’s Operational Infrastructure Support Program
American Cancer Society
American Heart Association
National Organization for Rare Disorders
Article History
Received: 7 September 2023
Accepted: 21 March 2024
First Online: 24 April 2024
Competing interests
: L.P. has financial interests in Edilytics and SeQure Dx. L.P.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. The remaining authors declare no competing interests.